50% OF ALL NDAs SUPPORTED SINCE 2014

EVENTS

Stop by our booth at an upcoming event, or hear from one of our thought leaders at a future conference.

ALL EVENTS


Webinar: FDA Guidance For ABPM: Capture the Data That Matters

In May of 2018, the FDA issued draft guidance advising sponsors on assessing a drug’s effect on blood pressure during a clinical trial. Clarified further in 2019, this guidance is the result of regulators looking for a connection between blood pressure and cardiovascular events during drug therapy. To learn more about this FDA guidance, ABPM, and blood pressure monitoring best practices, please join us on July 18.

Read More